Premium
Affective disorders: susceptibility and drug efficacy may be determined by the serotonin transporter promoter polymorphism
Author(s) -
Gurwitz David
Publication year - 2000
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1034/j.1399-0004.2000.570402.1.x
Subject(s) - serotonin transporter , pharmacogenomics , pharmacogenetics , antidepressant , drug , pharmacology , cyp2d6 , medicine , geneticist , serotonin , transporter , biology , genetics , bioinformatics , psychiatry , gene , genotype , anxiety , receptor